This result contradicts previous studies conducted by Mao et al.11 and Schneider et al.12 indicating CEA sensitivity of 29.1%, and 24%, respectively, in esophageal cancer which was lower than our result. This evidence concerns the gene CEACAM5 and esophageal cancer.